• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑来膦酸治疗大鼠模型中颌骨和股骨中成血管标志物的表达。

Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.

机构信息

Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.

Department of Orthodontics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

出版信息

BMC Res Notes. 2022 Jan 10;15(1):12. doi: 10.1186/s13104-021-05900-5.

DOI:10.1186/s13104-021-05900-5
PMID:35012647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8751108/
Abstract

OBJECTIVES

This study aimed to investigate the gene expression of angiogenic marker in surgically treated jawbones and femur on a rat model administrated with zoledronic acid.

RESULTS

No soft tissue fenestration or bone exposure was found in femur. Delayed soft tissue healing was found in both ZA group (3 in mandible, 4 in maxilla) and control group (1 in mandible, 2 in maxilla), while exposed bone was found only in the ZA group (1 in maxilla, 2 in mandible). RT-PCR analysis demonstrated no significant difference in gene expression of angiogenetic markers between ZA-treated and control groups in femur and mandible. In the maxilla, the expression of VEGFA and VEGFR-2 in medium-term ZA group was significantly down-regulated compared with that in the control. The ZA treatment does not change significantly the expression of the angiogenic factors in femur and mandible, but significantly downregulates the expression in maxilla in this rat model. The angiogenesis inhibition may contribute to the development of MRONJ but does not play a key role.

摘要

目的

本研究旨在探讨给予唑来膦酸的大鼠模型中手术治疗的颌骨和股骨中的血管生成标记物的基因表达。

结果

在股骨中未发现软组织窗或骨暴露。在 ZA 组(下颌骨 3 例,上颌骨 4 例)和对照组(下颌骨 1 例,上颌骨 2 例)中均发现软组织愈合延迟,而仅在 ZA 组(上颌骨 1 例,下颌骨 2 例)中发现暴露的骨。RT-PCR 分析表明,在股骨和下颌骨中,血管生成标记物的基因表达在 ZA 治疗组与对照组之间无显著差异。在上颌骨中,与对照组相比,中期 ZA 组 VEGFA 和 VEGFR-2 的表达显著下调。在该大鼠模型中,ZA 治疗不会显著改变股骨和下颌骨中血管生成因子的表达,但会显著下调上颌骨中的表达。血管生成抑制可能有助于 MRONJ 的发生,但不是关键作用。

相似文献

1
Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid.唑来膦酸治疗大鼠模型中颌骨和股骨中成血管标志物的表达。
BMC Res Notes. 2022 Jan 10;15(1):12. doi: 10.1186/s13104-021-05900-5.
2
Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid.唑来膦酸治疗大鼠颌骨和长骨手术干预的骨骼部位特异性反应。
Biomed Res Int. 2019 Dec 18;2019:5138175. doi: 10.1155/2019/5138175. eCollection 2019.
3
Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.短期唑来膦酸治疗对老年犬上颌骨和下颌骨手术部位骨重塑及愈合的影响。
J Oral Maxillofac Surg. 2011 Feb;69(2):418-27. doi: 10.1016/j.joms.2010.05.062. Epub 2010 Dec 3.
4
Comparison of Vascular Morphometry in Jawbones and Long Bones: Micro-CT Study in a Rat Model Treated with Zoledronic Acid.颌骨和长骨血管形态计量学的比较:唑来膦酸治疗大鼠模型的 micro-CT 研究。
Biomed Res Int. 2021 May 12;2021:6651318. doi: 10.1155/2021/6651318. eCollection 2021.
5
Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction.牙周炎诱导大鼠拔牙前颌骨药物相关性坏死。
BMC Oral Health. 2023 Aug 12;23(1):561. doi: 10.1186/s12903-023-03200-x.
6
Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.特立帕肽与双膦酸盐相关性颌骨骨坏死的治疗:大鼠模型。
Dentomaxillofac Radiol. 2014;43(1):20130144. doi: 10.1259/dmfr.20130144. Epub 2013 Oct 29.
7
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.从唑来膦酸转换为地舒单抗会增加骨转移患者发生药物相关性颌骨坏死的风险。
Cancer Chemother Pharmacol. 2021 Jun;87(6):871-877. doi: 10.1007/s00280-021-04262-w. Epub 2021 Mar 31.
8
Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.载有 E-rhBMP-2 的人工骨移植给药抑制 MRONJ 样小鼠模型拔牙窝骨坏死
Int J Mol Sci. 2021 Nov 26;22(23):12823. doi: 10.3390/ijms222312823.
9
Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.唑来膦酸治疗大鼠牙槽拔牙创中基质金属蛋白酶-9的表达
J Oral Maxillofac Surg. 2011 Nov;69(11):2698-707. doi: 10.1016/j.joms.2011.02.065. Epub 2011 Jul 12.
10
Zoledronic acid decreases bone formation without causing osteocyte death in mice.唑来膦酸可减少小鼠的骨形成而不引起骨细胞死亡。
Arch Oral Biol. 2009 Sep;54(9):851-6. doi: 10.1016/j.archoralbio.2009.06.002. Epub 2009 Jul 9.

引用本文的文献

1
Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.药物相关性颌骨坏死的遗传背景:当前证据和未来展望。
Int J Mol Sci. 2024 Sep 29;25(19):10488. doi: 10.3390/ijms251910488.
2
Treatment of medication-related osteonecrosis of the jaw with cell therapy.采用细胞疗法治疗药物相关性颌骨坏死。
Front Cell Dev Biol. 2024 Jan 26;12:1338376. doi: 10.3389/fcell.2024.1338376. eCollection 2024.
3
Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.药物相关性下颌骨坏死(MRONJ):发病机制假说和治疗策略的综述。
Arch Toxicol. 2024 Mar;98(3):689-708. doi: 10.1007/s00204-023-03653-7. Epub 2023 Dec 28.

本文引用的文献

1
Comparison of Vascular Morphometry in Jawbones and Long Bones: Micro-CT Study in a Rat Model Treated with Zoledronic Acid.颌骨和长骨血管形态计量学的比较:唑来膦酸治疗大鼠模型的 micro-CT 研究。
Biomed Res Int. 2021 May 12;2021:6651318. doi: 10.1155/2021/6651318. eCollection 2021.
2
Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid.唑来膦酸治疗大鼠颌骨和长骨手术干预的骨骼部位特异性反应。
Biomed Res Int. 2019 Dec 18;2019:5138175. doi: 10.1155/2019/5138175. eCollection 2019.
3
Wound healing protein profiles in the postoperative exudate of bisphosphonate-related osteonecrosis of mandible.双膦酸盐相关下颌骨坏死术后渗出液中的伤口愈合蛋白谱
Eur Arch Otorhinolaryngol. 2017 Sep;274(9):3485-3495. doi: 10.1007/s00405-017-4657-x. Epub 2017 Jun 24.
4
A case of mandible hypoplasia treated with autologous bone graft from mandibular symphysis: Expression of VEGF and receptors in bone regeneration.一例采用下颌骨联合自体骨移植治疗下颌骨发育不全的病例:骨再生中VEGF及其受体的表达
Acta Histochem. 2016 Jul;118(6):652-656. doi: 10.1016/j.acthis.2016.07.002. Epub 2016 Jul 16.
5
The bisphosphonate zoledronic acid regulates key angiogenesis-related genes in primary human gingival fibroblasts.双膦酸盐唑来膦酸可调节原代人牙龈成纤维细胞中关键的血管生成相关基因。
Arch Oral Biol. 2016 Mar;63:7-14. doi: 10.1016/j.archoralbio.2015.11.013. Epub 2015 Nov 23.
6
Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.长期静脉注射双膦酸盐治疗停药后双膦酸盐相关颌骨坏死患者的骨转换和血管生成血清标志物
J Oral Maxillofac Surg. 2016 Apr;74(4):738-46. doi: 10.1016/j.joms.2015.09.028. Epub 2015 Oct 3.
7
Correlation of changes in the mandible and retina/choroid vasculature of a rat model of BRONJ.双膦酸盐相关颌骨坏死大鼠模型下颌骨与视网膜/脉络膜血管系统变化的相关性
J Craniomaxillofac Surg. 2015 Sep;43(7):1144-50. doi: 10.1016/j.jcms.2015.05.021. Epub 2015 Jun 6.
8
Infection and medication-related osteonecrosis of the jaw.感染和药物相关的颌骨坏死。
J Dent Res. 2015 Apr;94(4):534-9. doi: 10.1177/0022034515572021. Epub 2015 Feb 20.
9
The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.含氮双膦酸盐(唑来膦酸和阿仑膦酸钠)对成骨细胞促血管生成因子产生的影响。
Cytokine. 2015 Feb;71(2):154-60. doi: 10.1016/j.cyto.2014.10.025. Epub 2014 Nov 17.
10
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.颌骨骨坏死的诊断和治疗:系统评价和国际共识。
J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405.